Dec 5, 2016
Washington Healthcare Update
This Week: More leadership changes in Congress…Cures legislation passes House, finally…the administration announces enrollment numbers.
4. State Activities
5. Regulations Open for Comment
Walden Elected Chairman of House Energy and Commerce Committee
On Dec. 1, Republicans elected Rep. Greg Walden (R-OR) to be the next chairman of the House Energy and Commerce Committee. Walden beat Reps. John Shimkus
(R-IL) and Joe Barton (R-TX) for the chairman post. He succeeds Rep. Fred Upton, who is stepping down as chairman due to Republican term limits.
Walden currently serves as head of the panel’s communications and technology subcommittee.
Rep. Nancy Pelosi Wins Another Term as Democratic Caucus Leader
House Minority Leader Nancy Pelosi (D-CA) swept aside a challenge from Rep. Tim Ryan (D-OH) on Nov. 30 to win another term atop the Democratic caucus,
ensuring continuity for Democrats despite their poor performance on Election Day.
Pelosi beat Ryan in a 134-63 vote, securing the two-thirds support within the caucus she had claimed earlier this month before Ryan officially jumped in
the race. Pelosi had vocal support from multiple lawmakers leading up to the election, who said her long-time tenure would be an asset heading into an
unprecedented period in Washington. They also blamed the party’s poor election performance on the top of the ticket.
Ryan argued that the party had failed to deliver a compelling message to blue-collar voters like those in his Ohio district, which he won easily even as
Hillary Clinton lost the area by a wide margin. He also earned the support of younger members frustrated at being frozen out of leadership.
Republicans will hold a 241-194 lead in House seats.
Levin Stepping Down as Top Ways and Means Democrat; Neal to be Ranking Member
Longtime Ways and Means Ranking Member Sandy Levin (D-MI) announced he is stepping down as the panel’s top Democrat. Levin said in a
letter to colleagues that Donald Trump’s recent election convinced him to step aside, both to allow younger House Democrats a chance to progress and to allow
himself to focus on policy issues. Levin, who is 85, had faced questions in recent years over whether it was time for Democrats to install a younger member
in his position.
Rep. Richard Neal (D-MA) was chosen to replace him as Ways and Means top Democrat on Dec. 1. Rep. John Lewis (D-GA), who was the next most senior Democrat
on the committee, was also nominated. However, he withdrew and threw his support to Neal. Neal pitched himself to colleagues as having the policy expertise
for the position, but also the ability to reach the white working-class voters and middle-class voters who defected from Democrats earlier this month.
Rep. Xavier Becerra (D-CA) had also announced his intention to run for the slot even though Rep. Neal was more senior on the committee. However, on Nov.
30, Gov. Jerry Brown (D-CA) announced that he was appointing Becerra as California’s attorney general.
21st Century Cures Legislation Finally Passes House, Senate Vote Next
The 21st Century Cures legislation, sponsored by Reps. Fred Upton
and Diana DeGette, finally passed the House on Dec. 2. The legislation now goes to the Senate where it is expected to pass without amendment early this
week, despite some opposition. The nearly 1,000-page bill includes $1 billion over two years to address the opioid epidemic and $500 million to help the
FDA implement changes called for in the legislation, though none of the funding is mandatory. It will have to be released to the Cures programs each year
by appropriators, which was a key post-election concession from Democrats. The mental health provisions in the bill have been watered down from a version
that passed the House earlier this year, and no longer include funding. They do, however, authorize new and existing treatment and prevention programs,
double-down on existing parity language and restructure the leadership at SAMHSA.
The legislation also includes several Medicare, electronic medical record and foster care reforms, as well as language from a bipartisan mental health
reform bill that was more than three years in the making.
In the Senate, Democratic senators Bernie Sanders, Elizabeth Warren and Jeff Merkley have said they will oppose the bill, citing concerns about weakened
FDA oversight and benefits to the drug industry. The White House, however, has said it “strongly supports” its passage.
Rep. Cole Says Appropriators Will Come Through With Cures Money
At the House Rules Committee hearing on Nov. 29, Rep. Tom Cole (R-OK) said House and Senate appropriators are committed to authorizing the new NIH funding
provided by 21st Century Cures.
Cole, who chairs the House Labor-HHS appropriations subcommittee, said appropriators in the coming years will also provide NIH with additional funding
beyond what is in the Cures bill.
The Cures bill provides $4.77 billion to NIH over 10 years.
Sen. Grassley Postpones Mylan EpiPen Hearing, Asks for SEC Investigation
The Senate Judiciary Committee postponed a previously scheduled Nov. 30 hearing on a potential settlement between Mylan and the Justice Department over the
EpiPen after representatives from the government and Mylan declined to testify. Senate Judiciary Chairman Chuck Grassley (R-IA) said he is looking at other
avenues for oversight of the pending $465 million settlement. Representatives from the Justice Department, CMS and Mylan have all declined to attend,
citing pending matters and investigations.
Mylan announced the settlement agreement in early October, which would resolve allegations that the company overcharged Medicaid for its lifesaving allergy
drug. Grassley wants to know whether the EpiPen settlement was proportional to what Mylan overcharged taxpayers and how much of the money will be returned
to the states.
The hearing would have more broadly focused on CMS authority to prevent and address drug misclassification and whether these misclassifications violate the
False Claims Act.
Sen. Grassley also wrote to the SEC asking for an investigation into whether Mylan misled investors about the settlement. Mylan said in a press release
that it had agreed to the terms of the $465 million settlement, however the Justice Department has maintained that it is not final yet.
“This seems to contradict Mylan’s claim that all potential liability claims have been resolved. Mylan made no mention of the fact that they are under an
SEC investigation in their press release,” Grassley said in the letter.
Grassley asked for an SEC response by Nov. 29.
CMS Releases 2015 National Health Expenditures
In 2015, per capita health care spending grew by 5.0 percent and overall health spending grew by 5.8 percent, according to a study by the Office of the
Actuary at the Centers for Medicare & Medicaid Services (CMS) published Dec. 2 as a Web First by Health Affairs. Those annual rates continue
to be below the rates of most years prior to passage of the Affordable Care Act. And, even as millions of people gained coverage, per-enrollee spending
growth in private health insurance and Medicare continues to be well below the average in the decade before passage of the Affordable Care Act.
The report concludes that 2015 expenditure growth was primarily the result of increased use and intensity of services as millions gained health coverage,
as well as continued significant growth in spending for retail prescription drugs. Spending on prescription drugs increased 9.0 percent in 2015, lower than
the 12.4 percent growth in 2014, yet significantly higher compared to 2.3 percent growth in 2013. On a per-enrollee basis, overall spending increased by
4.5 percent for private health insurance, 1.7 percent for Medicare and 3.8 percent for Medicaid.
The report noted that over a two-year period, 20.0 million individuals either gained private health insurance coverage or enrolled in the Medicaid program,
primarily as the result of the Affordable Care Act. The share of the population with health coverage increased from 86.0 percent in 2013 to 90.9 percent in
Additional highlights from the report:
Total per-enrollee private health insurance spending increased by 4.5 percent in 2015, compared to average growth in per-enrollee spending of
7.4 percent during 2000-2009. Overall, private health insurance expenditures (33 percent of total health care spending) reached $1.1 trillion in 2015,
and increased 7.2 percent in 2015. The faster rate of growth reflected increased enrollment in private health insurance associated with coverage
expansions under the Affordable Care Act, and a notable increase in the enrollment in employer-sponsored plans.
Per-enrollee Medicare spending increased by 1.7 percent, about the same rate as in 2014 and below the average annual growth in per-enrollee
spending during 2000-2009 of 7.0 percent (or 5.8 percent when Medicare Part D, which was implemented in 2006, is excluded). Medicare spending, which
represented 20 percent of national total health care spending in 2015, grew 4.5 percent to $646.2 billion, slightly slower than the 4.8 percent growth
in 2014 even as the leading edge of the baby boom generation joined Medicare. The 2015 rate of growth reflected mixed trends among services compared to
2014 as Medicare hospital spending growth slowed and nursing home and home health care spending grew faster. Medicare prescription drug spending
continued to grow by double digits with an 11.0 percent increase in 2015 following a 14.5 increase in 2014.
Overall Medicaid spending and enrollment grew at a slower rate in 2015 than in 2014 with per-enrollee Medicaid spending increasing 3.8 percent.
Medicaid spending, which totaled $545.1 billion, accounted for 17 percent of total spending on health care. Similarly, growth in Medicaid enrollment
slowed to 5.7 percent in 2015, significantly lower than the 2014 increase of 11.1 percent.
Retail prescription drug
spending continued to outpace overall health expenditure growth in 2015, increasing 9.0 percent to $324.6 billion after rising 12.4 percent in 2014.
Growth in prescription drug spending was faster than that of any other service in 2015. Recent rapid growth was due to increased spending for new
medicines (particularly for specialty drugs such as those used to treat hepatitis C), price growth in existing brand-name drugs, increased spending on
generics and a decrease in the number of expensive blockbuster drugs whose patents expired.
The CMS Office of the Actuary’s report can be found
CMS Updates ACA Federal Upper Limits
CMS recently released updated Affordable Care Act federal upper limits (FUL). The FULs, CMS said, were calculated in accordance with the Medicaid Covered
Outpatient Drug final rule with comment and are now available. To see the new FULs, click here.
States will have up to 30 days from the Dec. 1, 2016, effective date to implement the updated FULs.
For further information on the FUL program, click here.
Obamacare Enrollment Through HealthCare.gov Exceeds 2.1 Million
According to data released by CMS on
Nov. 30, more than 2.1 million customers have picked a plan through HealthCare.gov since Obamacare open enrollment began, and nearly one-quarter are new
Altogether, 1.6 million customers have renewed their coverage and roughly 520,000 shoppers have picked a new plan. Through the first four weeks of
enrollment, about 100,000 more people have signed up for coverage through HealthCare.gov compared to last year.
Thirty-nine states use HealthCare.gov, but nearly 1 million signups have been in just four states — Florida, Texas, North Carolina and Pennsylvania.
Enrollment may surge over the two next weeks, ahead of the Dec. 15 deadline to sign up for coverage starting Jan. 1. The administration expects that 13.8
million people will sign up for plans during this enrollment season, which ends Jan. 31.
CMS Falls Short on Obamacare Risk Corridor Payments Again
According to a recent memo, CMS
will pay another fraction of the money that insurers requested under Obamacare’s risk corridors program.
Insurers will not receive any of the money they are owed for the 2015 benefit year. The new funds instead will be used to fill the program’s $2.6 billion
deficit from 2014.
Therefore, CMS must still pay out the billions of dollars insurers requested for 2015 before the risk corridors program expires next year. Several insurers
are suing the Obama administration over the shortfall, arguing that it should allocate funds from outside CMS to help pay off the debt.
CMS Issues Medicaid and CHIP Eligibility and Appeals Final Rule
On Nov. 21, CMS issued a final rule that includes finalized Medicaid and the Children’s Health Insurance Program (CHIP) provisions associated with the
eligibility changes under the Affordable Care Act of 2010 and previous legislation. The final rule supports modernization of notices and appeals processes
and the coordination of eligibility notices and appeals across insurance affordability programs. Other provisions complement the simplification of
eligibility and enrollment and the shift to MAGI-based financial methodologies codified in the final rule published in March 2012, including coverage for
former foster care youth, optional eligibility pathways, financial methodologies for medically needy individuals and verification of citizenship and
immigration status. CMS also issued a Notice of Proposed Rulemaking (companion NPRM) relating to Medicaid and CHIP eligibility appeals processes that
complements the final rule.
To see the final rule,
click here. For the proposed rule,
Along with the two rules, CMCS issued an informational bulletin to inform states how they can pursue a Medicaid demonstration project under Section 1115 of
the Social Security Act to continue to provide Medicaid coverage to former foster care youth who aged out of foster care under the responsibility of
another state (and were enrolled in Medicaid while in foster care), and are now applying for Medicaid in the state in which they live.
The informational bulletin is available here.
House Asks Court to Halt Obamacare Lawsuit
On Nov. 21, the
House asked the D.C. Court of Appeals to temporarily halt its lawsuit challenging the legality of an Obamacare
subsidy program, a move that could allow the incoming Trump administration to quickly unwind the health care law.
Delaying the lawsuit, House v. Burwell, would allow the Trump administration to decide whether it wants to continue the Obama administration’s
defense of Obamacare’s cost-sharing subsidies. If the Trump administration were to decide to stop defending Obamacare, the cost-sharing subsidy payments to
health insurers may end.
If the subsidies stopped, health insurers could be allowed to almost immediately pull their insurance plans from the exchanges. That could force millions
off their health insurance and destabilize the Obamacare exchange market early next year.
“In light of public statements by the President-Elect and his campaign, there is at least a significant possibility of a meaningful change in policy in the
new Administration that could either obviate the need for resolution of this appeal or affect the nature and scope of the issues presented for review,” the
House lawyers wrote.
4. State Activities
Alaska: Alaska Posts Draft 1332 Waiver Proposal
Alaska has posted a
draft waiver proposal that asks the federal government to cover a significant share of the cost of its ACA
reinsurance program. Alaska appropriated $55 million for reinsurance in 2017 to shore up the state’s individual market, which had been at risk of
collapsing because of rising costs and insurer exits.
In the Section 1332 waiver application, Alaska argues that its state fund is limiting premium increases, and therefore the state is saving the federal
government money because it will spend less on premium tax credits. As a result, Alaska argues the state should receive federal “pass-through” funding
based on those savings to subsidize the cost of the program. State officials estimate that the reinsurance fund will save the federal government $51.6
million in tax credits for 2018 and increase individual market enrollment by nearly 1,650 people. The 1332 waiver would be effective at the start of 2018
for an initial period of five years. An actuarial analysis from Oliver Wyman is
posted here and the public hearing dates are here.
California: Gov. Jerry Brown Appoints Xavier Becerra as California’s Next Attorney General
On Dec. 1, California Gov. Jerry Brown nominated Democratic Rep. Xavier Becerra to be the state’s next attorney general. Sitting Attorney General Kamala
Harris was just elected to the U.S. Senate. Becerra was first elected to Congress from Los Angeles in 1992.
To see a related press release,
Kentucky: ER Visits Covered by Medicaid Up 16.7 Percent
According to a new study from the Foundation for a Healthy
Kentucky, ER visits covered by Medicaid are up 16.7 percentage points since 2012 because of expansion under the ACA. In 2015, roughly 47 percent of ER
visits were paid for by Medicaid, whereas in 2012 it was just over 30 percent. Even though the source of payment is changing, the foundation noted that the
number of ER visits overall has remained fairly steady even though more people are insured. In 2015, there were 2.2 million ER visits in the state, only
slightly more than the 2.1 million ER visits reported for 2014.
Michigan: State Health Department to Release Proposal on Spending $2 Billion for Mental Health Programs
Michigan’s health department is expected to release a draft proposal of how it will spend more than $2 billion in Medicaid funding for its mental health
system. Earlier this year, Gov. Rick Snyder supported a plan to privatize Michigan’s mental health care by contracting with Medicaid HMOs. But the plan
faced backlash from mental health advocates who said it could worsen patient care. The state legislature, instead, directed the health department to
develop a new proposal that is expected in December. A final report will be presented to the legislature in January.
Minnesota: OIG Finds State Misallocated Federal Funds in Setting Up ACA Exchange
Minnesota misallocated federal funds and claimed unallowable costs totaling nearly $1.3 million in setting up its ACA exchange, according to a new report from the HHS inspector general. The auditor found, for example, that the
exchange misallocated more than $346,000 in costs to federal exchange grants rather than having its state-run public programs cover those expenses. It also
did not appropriately authorize $930,000 for additional marketing work. The office recommended that Minnesota refund the misallocated funds to CMS but the
exchange did not agree.
Texas: Texas Reinstates Medicaid Coverage of Mosquito Repellent
In response to the first case of locally transmitted Zika, Texas officials are reinstating Medicaid coverage of mosquito repellent through December. Texas
Medicaid has a standing order for mosquito repellent prescriptions for pregnant women and women ages 10 to 45. Eligible women can obtain two repellent cans
per month from pharmacies.
The patient who contracted Zika is not pregnant and reported no recent travel to countries with ongoing Zika virus transmission. The announcement makes
Texas the second state to report local transmission of the virus.
The Texas announcement comes shortly after the World Health Organization declared that Zika was no longer considered an international public health
emergency but remains a “significant enduring public health challenge requiring intense action.”
Utah: Feds to Make Changes to Medicaid Expansion Plan
The federal government will likely make changes to Utah’s limited Medicaid expansion proposal, which is currently awaiting approval. As a result, the state
will not be able to begin enrollment on Jan. 1. The state projects that it would cover roughly 10,000 low-income adults who are chronically homeless, have
interacted with the criminal justice system or are in need of mental health or substance abuse treatment. It would also broaden access to more parents with
dependent children who couldn’t previously get Medicaid coverage.
Virginia: Legislature Setting Up Joint Subcommittee to Monitor Health Care
The Virginia legislature is setting up a new joint subcommittee tasked with monitoring health care changes that President-elect Donald Trump proposes,
including repealing Obamacare and revisions to other laws. Lawmakers say the new group would allow the legislature’s budget committees to respond more
quickly to changes under a Trump administration. Virginia has blocked Medicaid expansion under the ACA despite support from Democratic Gov. Terry
McAuliffe—this will likely not change given the Republican House and Trump administration.
5. Regulations Open for Comment
HHS Proposes Updates to Title X Rules
On Sept. 2, HHS
proposed to preclude Title X grant recipients from using criteria in
their selection of family planning providers that are unrelated to the
ability to deliver services effectively.
Since 2011, 13 states have attempted to restrict participation by family
planning providers in Title X based on factors unrelated to their ability to
provide services. The Title X program provides funding for certain family
planning services, including STD screening and treatment, but funding is not
used to pay for abortions. Although Planned Parenthood is not mentioned by
name in the proposed rule, it has often been the subject of defunding
actions by states and Congress.
In the proposed rule, HHS said the effects already felt by the restrictions
in many states justify the department’s rulemaking. HHS said grant
recipients that do not provide services directly would also be required to
follow the updated standards when choosing subrecipients.
HHS also proposed that a tiered structure governing how funds are
distributed would not be allowed unless it can be proven that a
provider in a top tier delivers Title X services more effectively than a
lower-tier provider. According to the Guttmacher Institute, a research
organization that supports reproductive rights, four states have a priority
system for distributing family planning funds, which often disadvantages
family planning centers.
CMS Releases Proposed Rule on Fire Safety Requirements for Dialysis Facilities
On Nov. 3, CMS announced a proposed rule to update Medicare
fire protection guidelines for certain dialysis facilities to ensure that patients are protected from fire while receiving treatment in those facilities.
The new proposed guidelines apply to all dialysis facilities that do not provide one or more exits at grade level from the treatment area level. CMS
previously updated the requirements to include dialysis facilities located adjacent to industrial high-hazard occupancies; however, as dialysis facilities
are not permitted to be located in such areas, the requirement specific to such geographically located facilities will be removed.
The rule adopts, for certain dialysis facilities, updated provisions of the National Fire Protection Association’s (NFPA) 2012 edition of the Life Safety
Code (LSC), as well as provisions of the NFPA’s 2012 edition of the Health Care Facilities Code in order to bring CMS’s requirements more up to date with
current fire safety standards. The LSC is a compilation of fire safety requirements for new and existing buildings, and is updated every three years.
The proposed rule addresses construction, protection and operational features of dialysis facilities to provide safety for Medicare beneficiaries from fire
and smoke. Some of the main requirements laid out in the rule include:
Doors to hazardous areas must be self-closing or must close automatically.
Alcohol-based hand rub dispensers now may be placed in corridors to allow for easier access.
A fire watch or building evacuation is required if the sprinkler system is out of service for more than 10 hours.
Currently, CMS is using the 2000 edition of the LSC to survey dialysis facilities for health and safety compliance. With this proposed rule, CMS is
adopting provisions of the 2012 edition of the LSC and provisions of the 2012 edition of the Health Care Facilities Code, to bring CMS’s requirements more
up to date, and align dialysis facility fire safety requirements with the codes CMS uses to survey other healthcare facilities.
CMS Releases Proposed Notice With Changes to Medicaid National Drug Rebate Agreement
On Nov. 7, CMS issued a proposed notice announcing changes that would be made to the Medicaid National Drug Rebate Agreement (NDRA) for use by the
Secretary of the Department of Health and Human Services and manufacturers under the Medicaid Drug Rebate Program. The NDRA is being updated to incorporate
legislative and regulatory changes that have occurred since the agreement was published in February 1991, as well as to make editorial and structural
revisions, such as references to the updated Office of Management and Budget (OMB)-approved data collection forms and electronic data reporting. There is a
90-day comment period for this proposed notice that will end on Feb. 7, 2017.
For more information, click here.
Comments Due on IMPACT Act Cross-Setting Quality Measure
On Nov. 4, CMS announced that public comments are due Nov. 17 on a cross-setting post-acute care measure under the Improving Medicare Post-Acute Care
Transformation Act of 2014 (IMPACT Act) to further develop and refine
the percentage of residents or patients with pressure ulcers that are new or worsened and language modifications being explored with the term “Pressure
Injury.” CMS seeks feedback on potential updates to measure specifications and items used to calculate the quality measure. Visit the Public Comment webpage
for more information.
CMS Issues Interim Final Rule to Delay Inclusion of U.S. Territories in Definitions of States and United States
CMS published the Covered Outpatient Drug Final Rule with Comment Period in the Federal Register on Feb. 1, 2016. As part of that
final rule with comment, CMS amended the regulatory definitions of “States” and “United States” to include the U.S. territories (American Samoa, the
Northern Mariana Islands, Guam, the Commonwealth of Puerto Rico and the U.S. Virgin Islands) beginning April 1, 2017. However, the agency said those
territories could not be ready to implement the program by this date.
Therefore, CMS issued an Interim Final Rule with comment period that delays the inclusion of the territories in the definitions of “States” and “United
States” from April 1, 2017, until April 1, 2020, which is effective on Nov. 15, 2016. There is a 60-day comment period that will end on Jan. 17, 2017.
For more information visit theCovered Outpatient Drugs Policy page on Medicaid.gov.
CMS Issues Proposed Rule for Medicaid Managed Care Plans
CMS has issued a new proposed rule detailing regulations for pass-through payments to providers from Medicaid managed care plans. The guidance builds on
the Medicaid managed care rule finalized by the Obama administration in May.
Read the proposed rule
here. It is scheduled to be
in the Federal Register on Nov. 22.
GAO Finds Improvements Needed in Veterans Health Care
GAO recently reviewed the Veterans Health Administration’s strategic planning process for health care and recommended that it clarify the responsibilities
of VA’s medical centers and develop an oversight process.
The VHA provided health care to 6.7 million veterans in fiscal year 2015. However, changes in the veteran population (such as more female veterans) could
affect VHA’s current strategies to provide quality health care. Effective strategic planning—such as identifying goals and methods to achieve them—can help
VHA respond to the changing health care needs of veterans, according to GAO.
To see the report, click here.
Commonwealth Fund Warns of Medicaid Changes
According to a new paper from the Commonwealth Fund,
efforts to turn states’ Medicaid funding stream into a block grant or a per capita cap would separate “funding considerations from the real-life needs that
have informed federal and state Medicaid policy for half a century.” Republicans in Congress have supported both of these ideas.
One of the paper’s authors, George Washington University health law professor Sara Rosenbaum, has previously argued that restructuring Medicaid into a
block grant program might be unconstitutional. Read her 2015 article in the New England Journal of Medicine.
Consumer Reports Reveals Poor Patient Safety in Several Teaching Hospitals
In a new analysis, Consumer Reports said
several high-profile teaching hospitals, including Robert Wood Johnson University Hospital and Dartmouth’s Hitchcock Medical Center, are not doing enough
to shield patients from certain bacterial infections.
The organization’s investigation of nearly 2,000 hospitals ranked 31 hospitals as low performers that failed to adequately protect against infections in
which bacteria enters a patient’s bloodstream through a catheter. Those central-line infections are particularly dangerous because they can quickly spread
to the heart and other vital organs, Consumer Reports said.
The poorest performers identified by Consumer Reports also include Emory University Hospital Midtown, George Washington University Hospital and
Ronald Reagan UCLA Medical Center.
listed 32 top performers as well, with Harvard-affiliated Mount Auburn Hospital and University of Chicago Medical Center among them.
Overall, however, the report said that central-line infections have fallen by 50 percent since 2008.
If you have any questions, contact the following individuals at
Kennan, Senior Vice President
Charlie Iovino, Vice
Caroline Perrin, Research Assistant
Founded in 1998, McGuireWoods Consulting LLC
(MWC) is a full-service public affairs firm offering infrastructure and
economic development, strategic communications & grassroots, and government
relations services. McGuireWoods Consulting is a subsidiary of the
law firm and has been named in The National Law Journal's special annual
report, "The Influence 50," for the past several years. In the most recent
report, McGuireWoods Consulting was ranked 15th of the 1,900 government
relations firms in Washington, D.C.
To sign up for the Weekly Washington Healthcare Update, use our online
McGuireWoods Consulting LLC
2001 K Street
Washington, DC 20006-1040